You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

REVEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Revex, and when can generic versions of Revex launch?

Revex is a drug marketed by Hikma and is included in one NDA.

The generic ingredient in REVEX is nalmefene hydrochloride. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the nalmefene hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Revex

A generic version of REVEX was approved as nalmefene hydrochloride by PURDUE PHARMA LP on February 8th, 2022.

  Try a Trial

US Patents and Regulatory Information for REVEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma REVEX nalmefene hydrochloride SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS 020459-001 Apr 17, 1995 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hikma REVEX nalmefene hydrochloride SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS 020459-002 Apr 17, 1995 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.